Showing 11,021 - 11,040 results of 31,209 for search '(( 50 ((ns decrease) OR (a decrease)) ) OR ( 5 ((wt decrease) OR (nn decrease)) ))', query time: 1.01s Refine Results
  1. 11021

    dPRPS plays a critical function during cellular response to oxidative stress. by Keemo Delos Santos (7349087)

    Published 2019
    “…<p>(A) Ovaries (upper panel) or fat bodies (lower panel) of adult <i>dPRPS GFP-trap</i> flies fed with PBS or PQT are immunostained for GFP (green) and DAPI (blue). …”
  2. 11022

    B[a]P treatment results in modulation of intracellular phosphop38 MAP kinase. by Kallol Dutta (215291)

    Published 2010
    “…Similarly, phosphoP38 MAP kinase level in 0.2 µM B[a]P treated group after 24 h, was significantly decreased as compared to that in 12 h post treatment group. …”
  3. 11023

    Blockade of Alk receptor activation abolishes neuronal differentiation due to Activin A treatment. by Griselda Rodríguez-Martínez (140821)

    Published 2012
    “…Co-treatment with Activin A and SB431542 or Activin A plus Follistatin decreased to the half mRNA expression for neuronal markers, while increased GFAP expression. …”
  4. 11024

    Association among Dietary Flavonoids, Flavonoid Subclasses and Ovarian Cancer Risk: A Meta-Analysis by Xiaoli Hua (2558284)

    Published 2016
    “…In a subgroup analysis by flavonoid subtypes, the ovarian cancer risk was also decreased for isoflavones (<i>RR</i> = 0.67, 95% CI = 0.50–0.92) and flavonols (<i>RR</i> = 0.68, 95% CI = 0.58–0.80). …”
  5. 11025

    Impact of mepolizumab in patients with high-burden severe asthma within a managed care population by Njira L. Lugogo (13119569)

    Published 2023
    “…Of the 264 patients with ≥1 OCS claim during baseline, 191 (72.3%) showed a decrease in mean daily OCS use by ≥50% in 117 patients (61.3%). …”
  6. 11026

    Effect of phyllanthus niruri on metabolic parameters of patients with kidney stone: a perspective for disease prevention by Nidia D. Pucci (5631659)

    Published 2018
    “…It increases urinary excretion of magnesium and potassium caused a significant decrease in urinary oxalate and uric acid in patients with hyperoxaluria and hyperuricosuria. …”
  7. 11027

    Raw data. by Changzhi Liu (518454)

    Published 2025
    “…This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.</p><p>Methods</p><p>A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. …”
  8. 11028
  9. 11029

    Baseline characteristics of the subjects. by Changzhi Liu (518454)

    Published 2025
    “…This study aimed to explore the association between RC levels and the risk of vertebral fractures in a longitudinal cohort.</p><p>Methods</p><p>A total of 1995 participants aged 50 years or older who underwent chest computed tomography (CT) scans for lung cancer screening between July 2016 and December 2019 were included in this study. …”
  10. 11030

    Knockdown of nr2f1a causes defects in zebrafish vascular development. by Bao-Jueng Wu (621818)

    Published 2014
    “…At the same stage ISVs are stalled at mid-somite in nr2f1a<sup>e2i2</sup> morphants (<b>D, F</b>). (<b>I</b>) Quantification of percentage of completed ISV shows a50% increase compared to <i>nr2f1a</i> morphants (n = 26 in wt and n = 34 in nr2f1aMO) at 30 hpf. …”
  11. 11031

    Parity and Pancreatic Cancer Risk: A Dose-Response Meta-Analysis of Epidemiologic Studies by Hong-Bo Guan (464993)

    Published 2014
    “…</p><p>Conclusion</p><p>In summary, these findings suggest that higher parity is associated with a decreased risk of PC. Future large consortia or pooled studies are warranted to fully adjust for potential confounders to confirm this association.…”
  12. 11032

    Table 1_Obinutuzumab in systemic lupus erythematosus: a real-world experience.docx by Chunmei Wu (3202050)

    Published 2025
    “…Objectives<p>To describe the real-world efficacy and safety of obinutuzumab in a heterogeneous systemic lupus erythematosus (SLE) population, including severe or refractory manifestations.…”
  13. 11033
  14. 11034
  15. 11035

    S2 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  16. 11036

    Study protocol. by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  17. 11037

    S1 Data - by Tamara Mogilevski (14239682)

    Published 2024
    “…</p><p>Methods</p><p>In a single-blinded, cross-over, randomised study, healthy volunteers received on separate days corticotropin-releasing hormone (CRH, 100 μg) or normal saline (as placebo) intravenously in random order, then a HFHC meal. …”
  18. 11038
  19. 11039
  20. 11040